Mülheim
Mülheim
Mülheim, Germany9 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study of Cabozantinib in Participants With Neuroendocrine Tumors Who Have Already Received Prior Treatment | Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, neoplasm, neuroendocrine neoplasm, primitive neuroectodermal tumor | Recruiting | Not stated | 2026-10-01 | NCT07314164 | |
| Treatment With Bempedoic Acid and/or Its Fixed-dose Combination With Ezetimibe in Primary Hypercholesterolemia or Mixed Dyslipidemia | Dyslipidemias, Hypercholesterolemia, Lipid Metabolism Disorders, Nutritional and Metabolic Diseases, hyperlipidemia, metabolic disease | Active, not recruiting | Not stated | 2026-09-30 | NCT04579367 | |
| Real-World Clinical Experience of Patients With Metastatic Castration-Resistant Prostate Cancer Treated With Olaparib + Abiraterone (PROceed) | Metastatic Castration-resistant Prostate Cancer | Active, not recruiting | Not stated | 2026-09-16 | NCT06380738 | |
| Chronic Limb-Threatening Ischemia Treated With Intravascular Lithotripsy Observational Study | Arterial Occlusive Diseases, Chronic Disease, Chronic Limb-Threatening Ischemia, Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, arteriosclerosis disorder, atherosclerosis, cardiovascular disorder, ischemic disease, peripheral arterial disease, peripheral vascular disease, vascular disorder | Active, not recruiting | Not stated | 2026-07-30 | NCT06149650 | |
| A NIS Evaluating Various Injectable and Oral Treatments in Patients With Relapsing Multiple Sclerosis | Relapsing Multiple Sclerosis | Recruiting | Not stated | 2026-07-30 | NCT05344469 | |
| Cemented TrendHip® - Multicenter PMCF Study on Total Indications | Femoral Fractures, Hip Dislocation, Hip Dysplasia, Hip Injuries, Joint Dislocations, Leg Injuries, Necrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, arthritic joint disease, arthropathy, autoimmune disease, bone disorder, bone fracture, connective tissue disorder, familial avascular necrosis of femoral head, hip fracture, immune system disorder, injury, musculoskeletal system disorder, osteoarthritis, osteoarthritis, hip, osteonecrosis, rheumatic disorder, rheumatoid arthritis | Active, not recruiting | Not applicable | 2026-02-24 | NCT04943328 | |
| Longterm-Evaluation of Vitelene® Against Standard | arthritic joint disease, arthropathy, musculoskeletal system disorder, osteoarthritis, osteoarthritis, hip, rheumatic disorder | Active, not recruiting | Not stated | 2025-11-17 | NCT01713062 | |
| Discontinuation of CDK4/6 Inhibitors in Patients With Metastatic HR Positive, HER2 Negative Breast Cancer | Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorder | Recruiting | Phase 2 | 2025-05-01 | NCT06207734 | |
| Post Market Follow-Up Study of the EVOLUTION® Total Knee Arthroplasty System With Cruciate Sacrificing Inserts | Skin and Connective Tissue Diseases, ankylosis, arthritic joint disease, arthropathy, autoimmune disease, connective tissue disorder, immune system disorder, musculoskeletal system disorder, osteoarthritis, rheumatic disorder, rheumatoid arthritis | Active, not recruiting | Not stated | 2022-10-13 | NCT02351414 |